As the CDC revises its COVID-19 vaccination recommendations, confusion reigns over who can get vaccinated this fall. Health experts and patients face barriers and uncertainty in access to vaccines.
In a revealing interview, Dr. Marty Makary, FDA commissioner, raises concerns over past Covid-19 vaccine recommendations, emphasizing the importance of discussions between patients and their doctors.
In a recent interview, FDA Commissioner Marty Makary sparked controversy by urging Americans to consult their doctors regarding Covid-19 vaccines, citing mixed data on their safety for children and pregnant individuals. As the government alters vaccine recommendations, public health experts express concern over potential risks.
A new COVID-19 variant, NB.1.8.1, is spreading quickly in California, leading health experts to warn of a potential summer surge. Learn about the symptoms, vaccine effectiveness, and what residents should know.
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
A new COVID subvariant has been detected in California, raising concerns of a potential summer wave. Changes in vaccine recommendations could limit access for pregnant women and children, experts warn.
In a surprising move, the CDC maintains Covid vaccine recommendations for children despite Health Secretary Kennedy's announcement to remove them. The new guidance raises concerns for pregnant women, leaving experts puzzled.
The White House is set to fix errors in Secretary Kennedy's 'Make America Healthy Again' report, which faced scrutiny for citing studies that don’t exist. Despite controversies, the report aims to transform public health policy.
In a surprising move, the Department of Health and Human Services has withdrawn millions in funding for Moderna's bird flu vaccine development, raising concerns about the nation's pandemic preparedness amid ongoing tensions over vaccine safety.
